var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('5/9 - 4:00 PM \; \; | \n'); } if (allow) { document.write('Alpine Immune Sciences Reports First Quarter 2024 Financial Results | \n'); } if (allow) { document.write('
4/29 - 10:39 PM \; \; | \n'); } if (allow) { document.write('SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRC, HRT, ALPN, MCBC | \n'); } if (allow) { document.write('
4/26 - 4:13 PM \; \; | \n'); } if (allow) { document.write('ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick &\; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN | \n'); } if (allow) { document.write('
4/23 - 12:06 PM \; \; | \n'); } if (allow) { document.write('SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AIRC, ALPN, WIRE | \n'); } if (allow) { document.write('
4/22 - 6:48 PM \; \; | \n'); } if (allow) { document.write('SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, LABP, SWAV, FUSN | \n'); } if (allow) { document.write('
4/17 - 7:51 PM \; \; | \n'); } if (allow) { document.write('INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN | \n'); } if (allow) { document.write('
4/12 - 5:17 PM \; \; | \n'); } if (allow) { document.write('ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick &\; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN | \n'); } if (allow) { document.write('
4/11 - 5:48 PM \; \; | \n'); } if (allow) { document.write('SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, JBT, ELYM, HRT | \n'); } if (allow) { document.write('
4/11 - 4:28 PM \; \; | \n'); } if (allow) { document.write('Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm | \n'); } if (allow) { document.write('
4/11 - 1:03 PM \; \; | \n'); } if (allow) { document.write('SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, ELYM, MODN | \n'); } if (allow) { document.write('
4/11 - 12:42 PM \; \; | \n'); } if (allow) { document.write('Thursday\'s ETF Movers: XBI, KIE [VIDEO] | \n'); } if (allow) { document.write('
4/10 - 9:51 PM \; \; | \n'); } if (allow) { document.write('Shareholder Alert: Ademi LLP investigates whether Alpine Immune Sciences, Inc. has obtained a Fair Price in its transaction with Vertex | \n'); } if (allow) { document.write('
4/10 - 4:15 PM \; \; | \n'); } if (allow) { document.write('Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy | \n'); } if (allow) { document.write('
4/10 - 4:01 PM \; \; | \n'); } if (allow) { document.write('Vertex Enters Into Agreement to Acquire Alpine Immune Sciences | \n'); } if (allow) { document.write('
4/10 - 4:01 PM \; \; | \n'); } if (allow) { document.write('Vertex Enters Into Agreement to Acquire Alpine Immune Sciences | \n'); } if (allow) { document.write('
4/1 - 9:00 AM \; \; | \n'); } if (allow) { document.write('Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024 | \n'); } if (allow) { document.write('
3/21 - 7:45 AM \; \; | \n'); } if (allow) { document.write('Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024 | \n'); } if (allow) { document.write('
3/20 - 4:30 PM \; \; | \n'); } if (allow) { document.write('Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune &\; Inflammatory Disease Virtual Conference | \n'); } if (allow) { document.write('
3/18 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results | \n'); } if (allow) { document.write('
3/7 - 4:30 PM \; \; | \n'); } if (allow) { document.write('Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results | \n'); } if (allow) { document.write('
more news | \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' |